Our new-found ability to profile the gene expression of a tumour is transforming the way we characterise cancers and decide on treatment. Laura van ‘t Veer was there from the start, and she’s now splitting her time between the academic and biotech sector, driving the translation of the new technique into diagnostic tools not just for research but for everyday clinical use.
Leave a Reply